Global Newswire by Notified: M&A

MARCH 27, 2024

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc.

Pharmaceutical 40

Pharmaceutical Equities Acquisitions IT 40

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

JD Supra: Mergers

JANUARY 22, 2024

Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. The timing of the announcement coincided with the start of the 42nd Annual J.P. By: Knobbe Martens

Pharmaceutical 180

Pharmaceutical Healthcare Corporation Equities 180

Global Newswire by Notified: M&A

SEPTEMBER 21, 2023

21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced today the completion of their acquisition of Paratek Pharmaceuticals, Inc. CAMBRIDGE, Mass.,

Pharmaceutical 40

Pharmaceutical Capital Acquisitions 40

Global Newswire by Notified: M&A

SEPTEMBER 25, 2023

25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. NASDAQ: REGN ) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., TARRYTOWN, N.Y., strengthening the company’s gene therapy and auditory programs.

Acquisitions 85

Acquisitions Pharmaceutical IT 85

Global Newswire by Notified: M&A

OCTOBER 6, 2023

PRESIDIO PROPERTY TRUST ANNOUNCES CLOSING OF MERGER OF ITS SPONSORED SPAC MURPHY CANYON ACQUISITION CORP NOW TRADING AS CONDUIT PHARMACEUTICALS.

Pharmaceutical 40

Pharmaceutical Mergers and Acquisitions Mergers Trading 40

Global Newswire by Notified: M&A

JULY 31, 2023

July 31, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. CORONA, Calif.,

Acquisitions 75

Acquisitions Pharmaceutical Corporation IT 75

Global Newswire by Notified: M&A

JUNE 18, 2024

(TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé ("Virage"), a company specializing in the manufacturing and marketing of natural health products ("NHPs"), based in Lévis, Quebec.

Acquisitions 40

Acquisitions Pharmaceutical Manufacturing IT 40

Global Newswire by Notified: M&A

NOVEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. VANCOUVER, British Columbia, Nov.

Pharmaceutical 49

Pharmaceutical Equities IT Negotiation 49

Global Newswire by Notified: M&A

OCTOBER 4, 2023

04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. Purchaser”), to purchase all outstanding shares of Zynerba common stock. The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.

Pharmaceutical 40

Pharmaceutical Shares Stock Acquisitions 40

The Guardian: Mergers & Acquisitions

MARCH 19, 2024

The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy.

Pharmaceutical 92

Pharmaceutical Portfolio Acquisitions Business 92

Global Newswire by Notified: M&A

JANUARY 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- Evaluate , a Norstella company, announced today the acquisition of J+D Forecasting , a leading provider of forecasting solutions for the pharmaceutical industry. London, UK & Boston, MA, Jan.

Acquisitions 40

Acquisitions Pharmaceutical 40

JD Supra: Mergers

MAY 26, 2023

s (Amgen) proposed acquisition of Horizon Therapeutics plc (Horizon). On May 17, 2023, the Federal Trade Commission (FTC) challenged Amgen Inc.’s The complaint is significant in three respects. By: Wilson Sonsini Goodrich & Rosati

Mergers 130

Mergers Pharmaceutical Trading Acquisitions 130

Global Newswire by Notified: M&A

JUNE 24, 2024

Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approximately.

Pharmaceutical 45

Pharmaceutical Business Acquisitions 45

Global Newswire by Notified: M&A

JULY 3, 2023

Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia

Acquisitions 40

Acquisitions Pharmaceutical Management 40

Global Newswire by Notified: M&A

DECEMBER 5, 2023

Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment

Acquisitions 45

Acquisitions Pharmaceutical Portfolio 45

Global Newswire by Notified: M&A

SEPTEMBER 26, 2023

OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired: CHINO HILLS, Calif., 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc.

Pharmaceutical 102

Pharmaceutical IT Manufacturing Acquisitions 102

The Guardian: Mergers & Acquisitions

DECEMBER 26, 2023

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker AstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market.

Pharmaceutical 80

Pharmaceutical Acquisitions IT Mergers and Acquisitions 80

Global Newswire by Notified: M&A

NOVEMBER 20, 2023

20, 2023 (GLOBE NEWSWIRE) -- Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is pleased to announce its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB.

Pharmaceutical 40

Pharmaceutical IT Electronics Manufacturing 40

Global Newswire by Notified: M&A

MARCH 5, 2024

Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. and Kyoto Biken Laboratories Inc.) under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which 50% from vaccines.

Pharmaceutical 52

Pharmaceutical Manufacturing Portfolio Acquisitions 52

Global Newswire by Notified: M&A

NOVEMBER 27, 2023

27, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Scientific Support Services Ltd (“SSS” or the “Company”), a UK based provider of scientific instruments, supplies and services to customers in the petrochemical, environmental, pharmaceutical, clinical, and food and flavors sectors.

Pharmaceutical 80

Pharmaceutical Food Acquisitions IT 80

Global Newswire by Notified: M&A

SEPTEMBER 20, 2023

Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets. Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets.

Pharmaceutical 52

Pharmaceutical Portfolio Acquisitions 52

Global Newswire by Notified: M&A

FEBRUARY 26, 2024

27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. MELBOURNE, Australia, Feb.

Manufacturing 40

Manufacturing Pharmaceutical Acquisitions IT 40

Global Newswire by Notified: M&A

JULY 31, 2023

ROTTERDAM, The Netherlands (1 August 2023) – IMCD N.V. IMCD” or “Company”), a global leading distribution partner, formulator of speciality chemicals and ingredients, and solutions provider, today announces that it signed an agreement to acquire 100% of the shares of Sachs Chemical, Inc. Sachs”).

Pharmaceutical 52

Pharmaceutical IT Acquisitions Shares 52

Global Newswire by Notified: M&A

JANUARY 22, 2024

22, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of RUWAG Handels AG (“RUWAG” or the “Company”), a provider of diagnostics and life sciences products and services, selling to hospitals, private labs, universities and pharmaceutical companies in Switzerland. LOS ANGELES, Jan.

Hospitality 49

Hospitality Pharmaceutical Acquisitions IT 49

Global Newswire by Notified: M&A

JULY 27, 2023

Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to.

Pharmaceutical 40

Pharmaceutical Acquisitions 40

Global Newswire by Notified: M&A

APRIL 29, 2024

The acquisition of Camlab bolsters Calibre Scientific’s growing product and service portfolio across the United Kingdom.

Pharmaceutical 45

Pharmaceutical Food Portfolio Acquisitions 45

Global Newswire by Notified: M&A

JULY 19, 2023

Tokyo, Japan and Cambridge , UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s announcement; “Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company.”

Investors 40

Investors Pharmaceutical Acquisitions Corporation 40

The Harvard Law School Forum

JUNE 16, 2023

In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Executive Summary This study addresses CVRs, the public M&A analog to the earnout used in private deals, which can be price-driven (e.g.,

M&A 64

M&A Pharmaceutical Acquisitions Valuation 64

Devensoft

MAY 25, 2023

Corporate restructuring can be a game-changer for any organization, whether it’s a merger, acquisition, or any other strategic move. Understanding merger vs acquisition Mergers and acquisitions (M&A) are two of the most common forms of corporate restructuring.

Corporation 52

Corporation Mergers Mergers and Acquisitions Acquisitions 52

Benchmark International

APRIL 18, 2024

The healthcare sector is primarily segmented into pharmaceuticals, services, devices, and others. According to Verified Market Research, the global healthcare market will reach $665.37 billion by 2028. By application, the industry is categorized by cardiovascular, oncology, anti-infection, central nervous system, respiratory, and others.

Healthcare 59

Healthcare Medical Pharmaceutical Mergers and Acquisitions 59

Global Newswire by Notified: M&A

JANUARY 15, 2024

15, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of MoBiTec GmbH (“MoBiTec” or the “Company”), a German supplier of consumables and services for molecular and cell biology. LOS ANGELES, Jan.

Pharmaceutical 40

Pharmaceutical Sale Acquisitions IT 40

The Risk Arbitrage Report

OCTOBER 23, 2022

. • Lg Chem Ltd (051915:KS) to acquire Aveo Pharmaceuticals Inc Com (AVEO). Advaxis Inc Com (ADXS) to acquire Ayala Pharmaceuticals Inc Com (AYLA). Closed Deals: • Thoma Bravo completes acquisition of Ping Identity Holding Corp Csh Mrg $28.50/Sh Vista Equity Partners completes acquisition of Avalara Inc Csh Mrg $93.50/Sh

Pharmaceutical 40

Pharmaceutical Acquisitions Equities Management 40

How2Exit

MARCH 31, 2024

Get the Insider Tips You Need to Secure Your Deal - Watch Here rn rn About the Guest(s): rn Patrick O'Connell is an experienced mergers and acquisitions (M&A) advisor with a profound depth of knowledge in buying and selling small businesses valued between one to $20 million. b' E200: Buying or Selling a Small Business?

Business 130

Business Mergers and Acquisitions Securities M&A 130

Wizenius

APRIL 27, 2023

One specific area where these laws are frequently applied is in the context of merger and acquisition transactions. To prevent this from happening, governments often have laws in place that regulate mergers and acquisitions to ensure that they do not create or enhance a monopoly or otherwise harm competition.

Mergers and Acquisitions 52

Mergers and Acquisitions Pharmaceutical Retail Acquisitions 52

The Harvard Law School Forum

JUNE 16, 2023

In recent months, the life sciences industry has seen the reemergence of contingent value rights, or CVRs, in public company acquisitions as a way to bridge a valuation gap between buyers and sellers. Executive Summary This study addresses CVRs, the public M&A analog to the earnout used in private deals, which can be price-driven (e.g.,

M&A 40

M&A Pharmaceutical Acquisitions Valuation 40

The Risk Arbitrage Report

NOVEMBER 27, 2022

Closed Deals: • Alcon Ag Com (ALC) completes acquisition of Aerie Pharmaceuticals Inc Csh Mrg @$15.25/Sh Management completes acquisition of Continental Resources Inc Csh Mrg @$74.28/Sh . • Smith Financial Corp to acquire Home Capital Group Inc Com (HMCBF). Paine Schwartz Partners to acquire Agrofresh Solutions Inc Com (AGFS).

Pharmaceutical 40

Pharmaceutical Acquisitions Capital Management 40